50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,660.94 (-0.87%)
DOW   29,319.74 (-0.91%)
QQQ   276.38 (+0.32%)
AAPL   151.76 (+0.88%)
MSFT   239.50 (+0.66%)
META   138.12 (-1.63%)
GOOGL   98.58 (-0.16%)
AMZN   115.84 (+1.81%)
TSLA   278.24 (+1.06%)
NVDA   123.62 (-1.23%)
NIO   17.72 (+0.45%)
BABA   79.24 (+0.56%)
AMD   67.03 (-1.37%)
T   15.81 (-1.25%)
MU   49.53 (-1.14%)
CGC   2.79 (-1.76%)
F   12.02 (-2.36%)
GE   65.03 (+0.74%)
DIS   98.84 (-0.66%)
AMC   7.40 (-7.38%)
PYPL   85.77 (-1.38%)
PFE   43.92 (-0.36%)
NFLX   226.12 (-0.13%)
S&P 500   3,660.94 (-0.87%)
DOW   29,319.74 (-0.91%)
QQQ   276.38 (+0.32%)
AAPL   151.76 (+0.88%)
MSFT   239.50 (+0.66%)
META   138.12 (-1.63%)
GOOGL   98.58 (-0.16%)
AMZN   115.84 (+1.81%)
TSLA   278.24 (+1.06%)
NVDA   123.62 (-1.23%)
NIO   17.72 (+0.45%)
BABA   79.24 (+0.56%)
AMD   67.03 (-1.37%)
T   15.81 (-1.25%)
MU   49.53 (-1.14%)
CGC   2.79 (-1.76%)
F   12.02 (-2.36%)
GE   65.03 (+0.74%)
DIS   98.84 (-0.66%)
AMC   7.40 (-7.38%)
PYPL   85.77 (-1.38%)
PFE   43.92 (-0.36%)
NFLX   226.12 (-0.13%)
S&P 500   3,660.94 (-0.87%)
DOW   29,319.74 (-0.91%)
QQQ   276.38 (+0.32%)
AAPL   151.76 (+0.88%)
MSFT   239.50 (+0.66%)
META   138.12 (-1.63%)
GOOGL   98.58 (-0.16%)
AMZN   115.84 (+1.81%)
TSLA   278.24 (+1.06%)
NVDA   123.62 (-1.23%)
NIO   17.72 (+0.45%)
BABA   79.24 (+0.56%)
AMD   67.03 (-1.37%)
T   15.81 (-1.25%)
MU   49.53 (-1.14%)
CGC   2.79 (-1.76%)
F   12.02 (-2.36%)
GE   65.03 (+0.74%)
DIS   98.84 (-0.66%)
AMC   7.40 (-7.38%)
PYPL   85.77 (-1.38%)
PFE   43.92 (-0.36%)
NFLX   226.12 (-0.13%)
S&P 500   3,660.94 (-0.87%)
DOW   29,319.74 (-0.91%)
QQQ   276.38 (+0.32%)
AAPL   151.76 (+0.88%)
MSFT   239.50 (+0.66%)
META   138.12 (-1.63%)
GOOGL   98.58 (-0.16%)
AMZN   115.84 (+1.81%)
TSLA   278.24 (+1.06%)
NVDA   123.62 (-1.23%)
NIO   17.72 (+0.45%)
BABA   79.24 (+0.56%)
AMD   67.03 (-1.37%)
T   15.81 (-1.25%)
MU   49.53 (-1.14%)
CGC   2.79 (-1.76%)
F   12.02 (-2.36%)
GE   65.03 (+0.74%)
DIS   98.84 (-0.66%)
AMC   7.40 (-7.38%)
PYPL   85.77 (-1.38%)
PFE   43.92 (-0.36%)
NFLX   226.12 (-0.13%)
NASDAQ:EVOK

Evoke Pharma - EVOK Stock Forecast, Price & News

$1.82
-0.13 (-6.64%)
(As of 09/26/2022 12:12 PM ET)
Add
Compare
Today's Range
$1.82
$1.97
50-Day Range
$1.95
$3.43
52-Week Range
$1.90
$17.40
Volume
901 shs
Average Volume
447,370 shs
Market Capitalization
$6.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EVOK stock logo

About Evoke Pharma (NASDAQ:EVOK) Stock

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Receive EVOK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evoke Pharma and its competitors with MarketBeat's FREE daily newsletter.

EVOK Stock News Headlines

EVOK Evoke Pharma, Inc.
StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK)
Evoke Flat on GIMOTI Results
See More Headlines
Receive EVOK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evoke Pharma and its competitors with MarketBeat's FREE daily newsletter.

EVOK Company Calendar

Last Earnings
8/10/2022
Today
9/26/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:EVOK
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Net Income
$-8,540,000.00
Net Margins
-372.04%
Pretax Margin
-370.75%

Debt

Sales & Book Value

Annual Sales
$1.62 million
Book Value
$1.31 per share

Miscellaneous

Free Float
3,000,000
Market Cap
$6.08 million
Optionable
Not Optionable
Beta
0.59

Key Executives

  • Mr. David A. Gonyer (Age 58)
    Co-Founder, CEO, Pres & Director
    Comp: $737.24k
  • Mr. Matthew J. D'Onofrio (Age 52)
    Co-Founder, Chief Bus. Officer, Exec. VP, Treasurer & Sec.
    Comp: $524.45k
  • Dr. Marilyn R. Carlson (Age 74)
    Chief Medical Officer
    Comp: $491.69k
  • Mr. Christopher Quesenberry
    Chief Commercial Officer - Gimoti (TM)













EVOK Stock - Frequently Asked Questions

How have EVOK shares performed in 2022?

Evoke Pharma's stock was trading at $6.60 on January 1st, 2022. Since then, EVOK shares have decreased by 70.5% and is now trading at $1.9495.
View the best growth stocks for 2022 here
.

When is Evoke Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our EVOK earnings forecast
.

How were Evoke Pharma's earnings last quarter?

Evoke Pharma, Inc. (NASDAQ:EVOK) released its quarterly earnings results on Wednesday, August, 10th. The specialty pharmaceutical company reported ($0.71) earnings per share for the quarter. The specialty pharmaceutical company had revenue of $0.46 million for the quarter. Evoke Pharma had a negative trailing twelve-month return on equity of 185.09% and a negative net margin of 372.04%.

When did Evoke Pharma's stock split?

Evoke Pharma shares reverse split on the morning of Monday, May 23rd 2022. The 1-12 reverse split was announced on Monday, May 23rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

What other stocks do shareholders of Evoke Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evoke Pharma investors own include Bank of Hawaii (BOH), InterDigital (IDCC), STAG Industrial (STAG), Advanced Micro Devices (AMD), Novavax (NVAX), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Pfizer (PFE), Gilead Sciences (GILD) and Bed Bath & Beyond (BBBY).

What is Evoke Pharma's stock symbol?

Evoke Pharma trades on the NASDAQ under the ticker symbol "EVOK."

Who are Evoke Pharma's major shareholders?

Evoke Pharma's stock is owned by a variety of institutional and retail investors. Top institutional investors include Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David A Gonyer and Matthew J D'onofrio.
View institutional ownership trends
.

How do I buy shares of Evoke Pharma?

Shares of EVOK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evoke Pharma's stock price today?

One share of EVOK stock can currently be purchased for approximately $1.95.

How much money does Evoke Pharma make?

Evoke Pharma (NASDAQ:EVOK) has a market capitalization of $6.52 million and generates $1.62 million in revenue each year. The specialty pharmaceutical company earns $-8,540,000.00 in net income (profit) each year or ($2.8709) on an earnings per share basis.

How can I contact Evoke Pharma?

Evoke Pharma's mailing address is 420 STEVENS AVENUE SUITE 370, SOLANA BEACH CA, 92075. The official website for the company is www.evokepharma.com. The specialty pharmaceutical company can be reached via phone at (858) 345-1494 or via email at tbui@theruthgroup.com.

This page (NASDAQ:EVOK) was last updated on 9/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.